Last week, in a sit-down interview with CNN, WeightWatchers CEO Sima Sistani uttered four words that changed the trajectory of the company for good: “We got it wrong.”
Since joining the company last year, Sistani has revised many of its core features, including shifting away from storefronts and their infamous in-person meetings, but most radical is her keen embrace of blockbuster weight loss and weight-management drugs like Ozempic and Wegovy, can help patients lose 22.5 percent of their body weight — approaching the amount someone would lose with bariatric surgery. As part of this pivot, WeightWatchers will be collaborating with a telehealth company that can prescribe their customers these medications.
